Promising proteins detected by Western blot from Echinococcus granulosus protoscoleces for predicting early post-surgical outcomes in CE-affected Tunisian children

Table 1 Overview of the clinical characteristics of the "non-relapsed" and "relapsed" cystic echinococcosis patient groups

Patients (n^a)	Sex		Median age (IQR) in years	Cyst localization and type^d								Treatment strategy
Patients (n^a)	F	M	Median age (IQR) in years	Lungs		Liver		Multiple^e		Other^f		Surgery only	Surgery plus ABZ^g
NRCE^b 39	17	22	8 (4–11)	17	CE1 (13) CE2 (2) CE3a (2)	12	CE1 (8) CE2 (1) CE3a (2) CE4 (1)	8	(CE1)	2	(CE1)	21	18
RCE^c 20	5	15	8 (6–11)	7	CE1 (6) CE3a (1)	6	CE1	7	(CE1)	0		17	3

^aTotal number of patients
^bNRCE. Non-relapsed cystic echinococcosis patients after 3 years post-surgery
^cRCE. Relapsed cystic echinococcosis patients at 1 year post-surgery
^dCyst classification according to WHO-IWGE [34]
^eMultiple localization means that cysts were located in the liver and the lungs (13 cases), the liver, lungs, and peritoneum (one case), and the liver, peritoneum, and brain (one case)
^fOther locations indicate two cases: one case with a cyst detected in the spleen and one patient with a peritoneal cyst
^gABZ. Albendazole medication was given post-operatively to patients with complicated cases and multicystic disease as 10 mg/kg per day

ISSN: 1756-3305